Is a timely assessment of the hematocrit necessary for cardiovascular magnetic resonance-derived extracellular volume measurements?
Journal
Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance
Journal Volume
22
Journal Issue
1
Pages
77
Date Issued
2020-11-30
Author(s)
Niisato, Emi
Chow, Kelvin
Yang, Shun-Chung
Abstract
Cardiovascular magnetic resonance (CMR)-derived extracellular volume (ECV) requires a hematocrit (Hct) to correct contrast volume distributions in blood. However, the timely assessment of Hct can be challenging and has limited the routine clinical application of ECV. The goal of the present study was to evaluate whether ECV measurements lead to significant error if a venous Hct was unavailable on the day of CMR.
Subjects
Cardiovascular magnetic resonance; Extracellular volume fraction; Hematocrit; T1 mapping
SDGs
Other Subjects
gadoterate meglumine; contrast medium; gadoterate meglumine; meglumine; organometallic compound; adult; analytic method; Article; blood analysis; cardiovascular magnetic resonance; cohort analysis; controlled study; correlation analysis; extracellular space; female; hematocrit; human; image analysis; intermethod comparison; major clinical study; male; measurement error; middle aged; partition coefficient; priority journal; retrospective study; adolescent; aged; blood; cardiac muscle; comparative study; diagnostic imaging; fibrosis; heart disease; metabolism; nuclear magnetic resonance imaging; pathology; predictive value; very elderly; young adult; Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fibrosis; Heart Diseases; Hematocrit; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Myocardium; Organometallic Compounds; Predictive Value of Tests; Young Adult
File(s)![Thumbnail Image]()
Loading...
Name
JCMR 2020.pdf
Size
3.24 MB
Format
Adobe PDF
Checksum
(MD5):9f7b8f75b3b82dcb5d313fc7d968ee4c